STAT3 and asthma: IL-5 induced STAT3/5 signaling plays a causative role in allergic asthma and is being targeted by Mepolizumab, which proves to be quite effective in reducing risk of asthma exacerbations as well as reduce dependence on corticosteroids [24,25,26,27].